Home › Biogen and Sobi Announce European Medicines Agency Validates...
 

Keywords :   


Biogen and Sobi Announce European Medicines Agency Validates...

2015-06-26 10:44:02| Appliances - Topix.net

CAMBRIDGE, Mass. & STOCKHOLM-- -- Biogen and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has accepted the Marketing Authorization Application of ALPROLIX A , a recombinant factor IX Fc fusion protein product candidate for the treatment of hemophilia B. This validation signifies the initiation of the EMA's review process.

Tags: agency european announce medicines

Category:Consumer Goods and Services

Latest from this category

All news
22.11'Scammers sent courier to steal 4,000'
22.11Spain fines budget airlines including Ryanair 179m
22.11Formulating Biphasic and Triphasic Products
22.11Gatwick terminal evacuated due to security risk
22.1168% of US households have a smart TV, 46% have a streaming media player
22.11Reliance and Disney complete India JV transaction
22.11HbbTV Association appoints Service List Registry
22.11ocilion brings Prime Video and YouTube to its IPTV platform
Consumer Goods and Services »
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »